Physician profile
Donna C Haley
NPI 1659337442
$842.60
in general payments reported to CMS, 2019-2025
21 companies · $76.30 in 2025
The $76.30 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $88.33 · 2025: $76.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $146.84 | 2019 | |
| Janssen Biotech, INC. | $110.96 | 2019 | |
| Pfizer INC. | $96.75 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.14 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $50.93 | 2019 | |
| Abbvie INC. | $38.62 | 2019-2020 | |
| Abiomed | $32.90 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.31 | 2019 | |
| Amgen INC. | $30.61 | 2019 | |
| Novo Nordisk INC | $30.14 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.04 | 2019-2020 | |
| Boston Scientific Corporation | $24.84 | 2025 | General - Pain Management |
| Hikma Pharmaceuticals USA | $18.58 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.56 | 2025 | Exparel |
| Medtronic USA, INC. | $18.13 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.47 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.83 | 2019 | |
| Amarin Pharma, INC. | $14.15 | 2020 | |
| Glaxosmithkline, LLC. | $13.73 | 2020 | |
| Assertio Therapeutics, INC. | $13.71 | 2019 | |
| Merck Sharp & Dohme LLC | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Haley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.